Equifax (EFX) Competitors $226.74 -0.46 (-0.20%) As of 02:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EFX vs. CCRN, CRAI, FI, G, IQV, IT, OMC, RHI, TRU, and WMShould you be buying Equifax stock or one of its competitors? The main competitors of Equifax include Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Fiserv (FI), Genpact (G), IQVIA (IQV), Gartner (IT), Omnicom Group (OMC), Robert Half (RHI), TransUnion (TRU), and Waste Management (WM). Equifax vs. Its Competitors Cross Country Healthcare Charles River Associates Fiserv Genpact IQVIA Gartner Omnicom Group Robert Half TransUnion Waste Management Cross Country Healthcare (NASDAQ:CCRN) and Equifax (NYSE:EFX) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends. Which has better valuation and earnings, CCRN or EFX? Equifax has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCross Country Healthcare$1.34B0.30-$14.56M-$0.26-47.80Equifax$5.68B4.94$604.10M$5.1144.37 Is CCRN or EFX more profitable? Equifax has a net margin of 10.95% compared to Cross Country Healthcare's net margin of -0.70%. Equifax's return on equity of 18.89% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Cross Country Healthcare-0.70% 1.72% 1.24% Equifax 10.95%18.89%7.84% Do institutionals & insiders hold more shares of CCRN or EFX? 96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 96.2% of Equifax shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by insiders. Comparatively, 1.4% of Equifax shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts prefer CCRN or EFX? Cross Country Healthcare currently has a consensus price target of $17.93, suggesting a potential upside of 44.28%. Equifax has a consensus price target of $280.93, suggesting a potential upside of 23.90%. Given Cross Country Healthcare's higher possible upside, equities analysts clearly believe Cross Country Healthcare is more favorable than Equifax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86Equifax 0 Sell rating(s) 8 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.67 Does the media prefer CCRN or EFX? In the previous week, Equifax had 25 more articles in the media than Cross Country Healthcare. MarketBeat recorded 29 mentions for Equifax and 4 mentions for Cross Country Healthcare. Equifax's average media sentiment score of 0.82 beat Cross Country Healthcare's score of 0.78 indicating that Equifax is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Equifax 11 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, CCRN or EFX? Cross Country Healthcare has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Equifax has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500. SummaryEquifax beats Cross Country Healthcare on 15 of the 17 factors compared between the two stocks. Get Equifax News Delivered to You Automatically Sign up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EFX vs. The Competition Export to ExcelMetricEquifaxConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$28.04B$6.40B$28.72B$21.69BDividend Yield0.87%1.76%2.88%3.59%P/E Ratio44.3322.1426.0832.38Price / Sales4.942.73968.6981.13Price / Cash17.8916.1532.2724.53Price / Book5.845.267.954.58Net Income$604.10M$272.15M$196.17M$1.01B7 Day Performance-1.46%0.00%0.53%1.11%1 Month Performance-13.60%-4.96%0.36%-0.71%1 Year Performance-19.11%-12.24%52.22%10.30% Equifax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFXEquifax4.9353 of 5 stars$226.74-0.2%$280.93+23.9%-21.8%$28.04B$5.68B44.3314,700Trending NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionCCRNCross Country Healthcare3.7057 of 5 stars$12.50+7.9%$17.93+43.4%+3.6%$409.50M$1.34B-48.088,205CRAICharles River Associates4.2909 of 5 stars$176.52-0.2%$235.00+33.1%-5.5%$1.16B$712.91M21.37940FIFiserv4.8904 of 5 stars$122.55-0.1%$202.73+65.4%-40.3%$66.62B$383.42M20.4638,000Trending NewsAnalyst DowngradeAnalyst RevisionGGenpact4.2621 of 5 stars$39.54+0.4%$52.29+32.2%-1.5%$6.89B$4.93B13.14140,000IQVIQVIA4.7449 of 5 stars$203.95+2.9%$236.45+15.9%-11.6%$34.67B$15.70B29.5288,000ITGartner4.7554 of 5 stars$245.46+2.5%$356.89+45.4%-55.6%$18.59B$6.30B15.1121,044News CoverageAnalyst ForecastOMCOmnicom Group4.7232 of 5 stars$76.62+0.2%$96.29+25.7%-26.8%$14.84B$15.91B10.9974,900Positive NewsUpcoming EarningsRHIRobert Half4.8876 of 5 stars$32.12+2.4%$45.00+40.1%-53.1%$3.27B$5.57B18.3514,700News CoverageUpcoming EarningsAnalyst ForecastTRUTransUnion4.7667 of 5 stars$77.75+0.1%$108.15+39.1%-26.5%$15.14B$4.36B38.8713,400Trending NewsUpcoming EarningsAnalyst RevisionWMWaste Management4.7667 of 5 stars$217.17-0.9%$254.32+17.1%-0.1%$87.48B$22.06B32.2261,700Analyst Forecast Related Companies and Tools Related Companies Cross Country Healthcare Alternatives Charles River Associates Alternatives Fiserv Alternatives Genpact Alternatives IQVIA Alternatives Gartner Alternatives Omnicom Group Alternatives Robert Half Alternatives TransUnion Alternatives Waste Management Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EFX) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equifax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equifax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
